MCMCB Pro
G8723

G8723Specimen site is other than anatomic location of primary tumor

HCPCSActiveBETOS M5B

G8723 is a HCPCS Level II code for specimen site is other than anatomic location of primary tumor. It belongs to the Procedures and Professional Services (Temporary) section. Whether Medicare pays it depends on the coverage rule below.

Medicare coverage: Carrier judgment

Coverage is decided by your Medicare contractor, not by national policy. Whether this is paid depends on the LCD for your jurisdiction and on what the documentation supports.

From the coverage field of the CMS Alpha-Numeric HCPCS File, release 2026Q3-Jul. This states Medicare’s position on the code, not on your particular claim.

Physician fee schedule statusM

Measurement code. Used for reporting purposes only; never paid.

Global period: XXX

Want the dollar amount for your locality? The fee calculator applies your GPCI and the current conversion factor.

The CMS record for G8723

Long descriptor
Specimen site is other than anatomic location of primary tumor

The official wording. This is what the code means.

Short descriptor
Spec sit not prim tumor

CMS's 28-character form, which is what shows up on a remittance advice.

Added
January 1, 2012

When CMS introduced the code.

BETOS
M5B

Berenson-Eggers Type of Service — CMS's own analytic grouping.

Pricing indicator
00 — Not priced by Part B

Service not separately priced by Part B — not covered, bundled into another service, or used by Part A only.

Codes adjacent to G8723

HCPCS has no hierarchy — related items simply sit next to each other in the numbering. If G8723 is not quite right, the correct code is very often within a few positions of it.

  • G8712Antibiotic not prescribed or dispensed
  • G8713Spkt/v greater than or equal to 1.2 (single-pool clearance of urea [kt] / volume [v])terminated
  • G8714Hemodialysis treatment performed exactly three times per week for > 90 daysterminated
  • G8717Spkt/v less than 1.2 (single-pool clearance of urea [kt] / volume [v]), reason not giventerminated
  • G8718Total kt/v greater than or equal to 1.7 per week (total clearance of urea [kt] / volume [v])terminated
  • G8720Total kt/v less than 1.7 per week (total clearance of urea [kt] / volume [v])terminated
  • G8721Pt category (primary tumor), pn category (regional lymph nodes), and histologic grade were documented in pathology report
  • G8722Documentation of medical reason(s) for not including the pt category, the pn category or the histologic grade in the pathology report (e.g., re-excision without residual tumor; non-carcinomasanal canal)
  • G8724Pt category, pn category and histologic grade were not documented in the pathology report, reason not given
  • G8725Fasting lipid profile performed (triglycerides, ldl-c, hdl-c and total cholesterol)terminated
  • G8726Clinician has documented reason for not performing fasting lipid profile (e.g., patient declined, other patient reasons)terminated
  • G8728Fasting lipid profile not performed, reason not giventerminated
  • G8730Pain assessment documented as positive using a standardized tool and a follow-up plan is documentedterminated
  • G8731Pain assessment using a standardized tool is documented as negative, no follow-up plan requiredterminated
  • G8732No documentation of pain assessment, reason not giventerminated
  • G8733Elder maltreatment screen documented as positive and a follow-up plan is documented

Questions about G8723

What is HCPCS code G8723?

G8723 is a HCPCS Level II code for specimen site is other than anatomic location of primary tumor. It sits in the Procedures and Professional Services (Temporary) section.

Does Medicare cover G8723?

The CMS HCPCS file marks G8723 as "Carrier judgment". Coverage is decided by your Medicare contractor, not by national policy. Whether this is paid depends on the LCD for your jurisdiction and on what the documentation supports.

How is G8723 paid under the physician fee schedule?

G8723 carries PFS status code M. Measurement code. Used for reporting purposes only; never paid.

HCPCS Level II2026Q3-Jul· effective July 1, 2026